Ingenol mebutate Completed Phase N/A Trials for Actinic Keratosis (AK)

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02594436The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice
NCT02421471PMS to Evaluate the Safety and Efficacy of Picato® Gel
NCT02362152The Real Life Topical Field Treatment of Actinic Keratosis Study